Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis

Nature Medicine

Volumn 10, Issue 1, 2004, Pages 64-71

  Avecilla, Scott T ^a   Hattori, Koichi ^a   Heissig, Beate ^a   Tejada, Rafael ^a   Liao, Fang ^b   Shido, Koji ^a   Jin, David K ^a   Dias, Sergio ^a   Zhang, Fan ^a   Hartman, Travis E ^a   Hackett, Neil R ^a   Crystal, Ronald G ^a   Witte, Larry ^b   Hicklin, Daniel J ^b   Bohlen, Peter ^b   Eaton, Dan ^c   Lyden, David ^a   De Sauvage, Fredric ^c   Rafii, Shahin ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; FIBROBLAST GROWTH FACTOR 4; INTERLEUKIN 11; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; CADHERIN; CYTOKINE RECEPTOR; LEUKOCYTE ANTIGEN; MPL PROTEIN, MOUSE; ONCOPROTEIN; THROMBOPOIETIN RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW SUPPRESSION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; HEMATOPOIETIC CELL; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; ANIMAL; CELL ADHESION; CELL MOTION; CYTOLOGY; GENETICS; HEMATOPOIETIC STEM CELL; PHYSIOLOGY; VASCULARIZATION;

ANIMALIA;

ANIMALS; ANTIGENS, CD; BONE MARROW; CADHERINS; CELL ADHESION; CELL MOVEMENT; CHEMOKINES; HEMATOPOIETIC STEM CELLS; MEGAKARYOCYTES; MICE; ONCOGENE PROTEINS; RECEPTORS, CXCR4; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 11144356721     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm973     Document Type: Article

References (50)

1. de Sauvage, F.J. et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369, 533-538 (1994).
2. Lok, S. et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565-568 (1994).
3. Kaushansky, K. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369, 568-571 (1994).
4. Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 91, 11104-11108 (1994).
5. Bartley, T.D. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117-1124 (1994).
6. Gurney, A.L., Carver-Moore, K., de Sauvage, F.J. & Moore, M.W. Thrombocytopenia in c-mpl-deficient mice. Science 265, 1445-1447 (1994).
7. Gurney, A.L. & de Sauvage, F.J. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction. Stem Cells 14 (suppl. 1), 116-123 (1996).
8. Bunting, S. et al. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90, 3423-3429 (1997).
9. de Sauvage, F.J. et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J. Exp. Med. 183, 651-656 (1996).
10. Zucker-Franklin, D. & Philipp, C.S. Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept. Am. J. Pathol. 157, 69-74 (2000).
11. Tavassoli, M. & Aoki, M. Localization of megakaryocytes in the bone marrow. Blood Cells 15, 3-14 (1989).
12. Chen, Q., Solar, G., Eaton, D.L. & de Sauvage, F.J. IL-3 does not contribute to platelet production in c-Mpl-deficient mice. Stem Cells 16 (suppl. 2), 31-36 (1998).
13. Gainsford, T. et al. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Blood 91, 2745-2752 (1998).
14. Gainsford, T. et al. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Blood 95, 528-534 (2000).
15. Hamada, T. et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J. Exp. Med. 188, 539-548 (1998).
16. Wang, J.F., Liu, Z.Y. & Groopman, J.E. The α-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 92, 756-764 (1998).
17. Riviere, C. et al. Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis. Blood 93, 1511-1523 (1999).
18. Lane, W.J. et al. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood 96, 4152-4159 (2000).
19. Majka, M. et al. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood 96, 4142-4151 (2000).
20. Konishi, H. et al. Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene. J. Clin. Invest. 96, 1125-1130 (1995).
21. Sakamoto, H. et al. Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo. Proc. Natl. Acad. Sci. USA 91, 12368-12372 (1994).
22. Casella, I. et al. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. Blood 101, 1316-1323 (2003).
23. Rafii, S. et al. Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood 84, 10-19 (1994).
24. Rafii, S. et al. Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood 86, 3353-3363 (1995).
25. Corada, M. et al. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97, 1679-1684 (2001).
26. Su, W.H., Chen, H.I. & Jen, C.J. Differential movements of VE-cadherin and PECAM-1 during transmigration of polymorphonuclear leukocytes through human umbilical vein endothelium. Blood 100, 3597-3603 (2002).
27. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637 (2002).
28. + stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849 (2002).
29. Liao, F. et al. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res. 62, 2567-2575 (2002).
30. Avraham, H., Banu, N., Scadden, D.T., Abraham, J. & Groopman, J.E. Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 83, 2126-2132 (1994).
31. Avraham, H., Cowley, S., Chi, S.Y., Jiang, S. & Groopman, J.E. Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J. Clin. Invest. 91, 2378-2384 (1993).
32. Avraham, H. et al. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood 80, 1679-1684 (1992).
33. -/- mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Blood 98, 1019-1027 (2001).
34. Petit, I. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694 (2002).
35. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-851 (1999).
36. Kuter, D.J. & Begley, C.G. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100, 3457-3469 (2002).
37. Kuter, D.J. Whatever happened to thrombopoietin? Transfusion 42, 279-283 (2002).
38. Vadhan-Raj, S. et al. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer. Ann. Intern. Med. 132, 364-368 (2000).
39. Mossuz, P., Schweitzer, A., Molla, A. & Berthier, R. Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro. Br. J. Haematol. 98, 819-827 (1997).
40. Hodohara, K., Fujii, N., Yamamoto, N. & Kaushansky, K. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 95, 769-775 (2000).
41. Delehanty, L.L. et al. Stromal inhibition of megakaryocytic differentiation is associated with blockade of sustained Rap1 activation. Blood 101, 1744-1751 (2003).
42. Zweegman, S., Veenhof, M.A., Huijgens, P.C., Schuurhuis, G.J. & Drager, A.M. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Exp. Hematol. 28, 401-410 (2000).
43. Rafii, S., Mohle, R., Shapiro, F., Frey, B.M. & Moore, M.A. Regulation of hematopoiesis by microvascular endothelium. Leuk. Lymphoma 27, 375-386 (1997).
44. Almeida-Porada, G. & Ascensao, J.L. Isolation, characterization, and biologic features of bone marrow endothelial cells. J. Lab. Clin. Med. 128, 399-407 (1996).
45. Schweitzer, K.M. et al. Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am. J. Pathol. 148, 165-175 (1996).
46. Masek, L.C., Sweetenham, J.W., Whitehouse, J.M. & Schumacher, U. Immuno-, lectin-, and enzyme-histochemical characterization of human bone marrow endothelium. Exp. Hematol. 22, 1203-1239 (1994).
47. Mohle, R., Green, D., Moore, M.A., Nachman, R.L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA 94, 663-668 (1997).
48. Vadhan-Raj, S. et al. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia. J. Clin. Oncol. 21, 3158-3167 (2003).
49. Schabath, R. et al. The murine chemokine receptor CXCR4 is tightly regulated during T cell development and activation. J. Leukoc. Biol. 66, 996-1004 (1999).
50. Forster, R. et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J. Immunol. 160, 1522-1531 (1998).